Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Long-term outcomes of high dose treatment and autologous stem cell transplantation in follicular and mantle cell lymphomas - a single centre experience.

Boltezar L, Pintaric K, Pretnar J, Pohar Perme M, Novakovic BJ.

Radiol Oncol. 2016 Jun 24;51(1):81-87. doi: 10.1515/raon-2016-0040. eCollection 2017 Mar 1.

2.

Autologous hematopoietic stem cell transplantation in lymphoma patients is associated with a decrease in the double strand break repair capacity of peripheral blood lymphocytes.

Lacoste S, Bhatia S, Chen Y, Bhatia R, O'Connor TR.

PLoS One. 2017 Feb 16;12(2):e0171473. doi: 10.1371/journal.pone.0171473. eCollection 2017.

3.

Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments.

Juric MK, Ghimire S, Ogonek J, Weissinger EM, Holler E, van Rood JJ, Oudshoorn M, Dickinson A, Greinix HT.

Front Immunol. 2016 Nov 9;7:470. eCollection 2016. Review.

4.

Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.

Battiwalla M, Tichelli A, Majhail NS.

Biol Blood Marrow Transplant. 2017 Feb;23(2):184-192. doi: 10.1016/j.bbmt.2016.11.004. Epub 2016 Nov 3. Review.

PMID:
27818318
5.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Morton LM, Saber W, Baker KS, Barrett AJ, Bhatia S, Engels EA, Gadalla SM, Kleiner DE, Pavletic S, Burns LJ.

Biol Blood Marrow Transplant. 2017 Mar;23(3):367-378. doi: 10.1016/j.bbmt.2016.09.005. Epub 2016 Sep 12.

PMID:
27634019
6.

Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood.

Bomken S, Skinner R.

Children (Basel). 2015 Apr 21;2(2):146-73. doi: 10.3390/children2020146. Review.

7.

Relationship between paediatric CT scans and subsequent risk of leukaemia and brain tumours: assessment of the impact of underlying conditions.

Berrington de Gonzalez A, Salotti JA, McHugh K, Little MP, Harbron RW, Lee C, Ntowe E, Braganza MZ, Parker L, Rajaraman P, Stiller C, Stewart DR, Craft AW, Pearce MS.

Br J Cancer. 2016 Feb 16;114(4):388-94. doi: 10.1038/bjc.2015.415.

8.

Therapy-related acute myeloid leukemia in patients with lymphoma: A report of four cases and review of the literature.

Yang D, Fu X, Zhang X, Li W, Zhang M.

Oncol Lett. 2015 Nov;10(5):3261-3265. Epub 2015 Sep 15.

9.

Isolated clonal cytogenetic abnormalities after high-dose therapy.

Showel MM, Brodsky RA, Tsai HL, Briel KM, Kowalski J, Griffin CA, Jones RJ.

Biol Blood Marrow Transplant. 2014 Aug;20(8):1130-8. doi: 10.1016/j.bbmt.2014.03.033. Epub 2014 Apr 13.

11.

Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients.

Akhtari M, Bhatt VR, Tandra PK, Krishnamurthy J, Horstman H, Dreessen A, Chen PX, Armitage JO.

Cancer Biol Ther. 2013 Dec;14(12):1077-88. doi: 10.4161/cbt.26342. Epub 2013 Oct 18. Review.

12.

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Lint MT, Wingard JR, Tichelli A.

Rev Bras Hematol Hemoter. 2012;34(2):109-33. doi: 10.5581/1516-8484.20120032.

13.

Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphoma.

Khouri IF, Champlin RE.

Cancer J. 2012 Sep-Oct;18(5):457-62. Review.

14.

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A; Center for International Blood and Marrow Transplant Research (CIBMTR).; American Society for Blood and Marrow Transplantation (ASBMT).; European Group for Blood and Marrow Transplantation (EBMT).; Asia-Pacific Blood and Marrow Transplantation Group (APBMT).; Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ).; East Mediterranean Blood and Marrow Transplantation Group (EMBMT).; Sociedade Brasileira de Transplante de Medula Ossea (SBTMO)..

Hematol Oncol Stem Cell Ther. 2012;5(1):1-30. doi: 10.5144/1658-3876.2012.1.

15.

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A; Center for International Blood and Marrow Transplant Research.; American Society for Blood and Marrow Transplantation.; European Group for Blood and Marrow Transplantation.; Asia-Pacific Blood and Marrow Transplantation Group.; Bone Marrow Transplant Society of Australia and New Zealand.; East Mediterranean Blood and Marrow Transplantation Group.; Sociedade Brasileira de Transplante de Medula Ossea..

Bone Marrow Transplant. 2012 Mar;47(3):337-41. doi: 10.1038/bmt.2012.5.

16.

Second malignant neoplasms and cardiovascular disease following radiotherapy.

Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr.

J Natl Cancer Inst. 2012 Mar 7;104(5):357-70. doi: 10.1093/jnci/djr533. Epub 2012 Feb 6. Review.

17.

Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.

Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A; Center for International Blood and Marrow Transplant Research (CIBMTR).; American Society for Blood and Marrow Transplantation (ASBMT).; European Group for Blood and Marrow Transplantation (EBMT).; Asia-Pacific Blood and Marrow Transplantation Group (APBMT).; Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ).; East Mediterranean Blood and Marrow Transplantation Group (EMBMT),.; Sociedade Brasileira de Transplante de Medula Ossea (SBTMO)..

Biol Blood Marrow Transplant. 2012 Mar;18(3):348-71. doi: 10.1016/j.bbmt.2011.12.519. Epub 2011 Dec 13.

18.

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy.

Zimmerman Z, Scott BL, Gopal AK, Sandmaier BM, Maloney DG, Deeg HJ.

Bone Marrow Transplant. 2012 Jun;47(6):804-9. doi: 10.1038/bmt.2011.180. Epub 2011 Sep 12.

19.

Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.

Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, Sorror ML, Horowitz MM, Bolwell B, Rizzo JD, Socié G.

J Clin Oncol. 2011 Jun 1;29(16):2230-9. doi: 10.1200/JCO.2010.33.7212. Epub 2011 Apr 4.

20.

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.

Litzow MR, Tarima S, Pérez WS, Bolwell BJ, Cairo MS, Camitta BM, Cutler CS, de Lima M, Dipersio JF, Gale RP, Keating A, Lazarus HM, Luger S, Marks DI, Maziarz RT, McCarthy PL, Pasquini MC, Phillips GL, Rizzo JD, Sierra J, Tallman MS, Weisdorf DJ.

Blood. 2010 Mar 4;115(9):1850-7. doi: 10.1182/blood-2009-10-249128. Epub 2009 Dec 23.

Supplemental Content

Support Center